{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:12Z","timestamp":1794047412244,"version":"4.8.0"},"reference-count":59,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"1","license":[{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Anemia is a major health issue and associated with increased morbidity. Iron deficiency anemia (IDA) is the most prevalent, followed by anemia of chronic disease (ACD). IDA and ACD often co-exist, challenging diagnosis and treatment. While iron supplementation is the first-line therapy for IDA, its optimal route of administration and the efficacy of different repletion strategies in ACD are elusive. Female Lewis rats were injected with group A streptococcal peptidoglycan-polysaccharide (PG-APS) to induce inflammatory arthritis with associated ACD and\/or repeatedly phlebotomized and fed with a low iron diet to induce IDA, or a combination thereof (ACD\/IDA). Iron was either supplemented by daily oral gavage of ferric maltol or by weekly intravenous (i.v.) injection of ferric carboxymaltose for up to 4 weeks. While both strategies reversed IDA, they remained ineffective to improve hemoglobin (Hb) levels in ACD, although oral iron showed slight amelioration of various erythropoiesis-associated parameters. In contrast, both iron treatments significantly increased Hb in ACD\/IDA. In ACD and ACD\/IDA animals, i.v. iron administration resulted in iron trapping in liver and splenic macrophages, induction of ferritin expression and increased circulating levels of the iron hormone hepcidin and the inflammatory cytokine interleukin-6, while oral iron supplementation reduced interleukin-6 levels. Thus, oral and i.v. iron resulted in divergent effects on systemic and tissue iron homeostasis and inflammation. Our results indicate that both iron supplements improve Hb in ACD\/IDA, but are ineffective in ACD with pronounced inflammation, and that under the latter condition, i.v. iron is trapped in macrophages and may enhance inflammation.<\/jats:p>","DOI":"10.3324\/haematol.2022.281149","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T15:10:14Z","timestamp":1657206614000},"page":"135-149","source":"Crossref","is-referenced-by-count":27,"title":["Comparative analysis of oral and intravenous iron therapy in rat models of inflammatory anemia and iron deficiency"],"prefix":"10.3324","volume":"108","author":[{"given":"Lara Valente","family":"De Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Petzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Asshoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Theurl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Tymoszuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Seifert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natascha","family":"Brigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hilbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egon","family":"Demetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Von Raffay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Barros-Pinkelnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenter","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2022,7,7]]},"reference":[{"key":"43012","doi-asserted-by":"crossref","unstructured":"Kassebaum NJ, Collaborators GBDA. The global burden of anemia. Hematol Oncol Clin North Am. 2016; 30(2):247-308.","DOI":"10.1016\/j.hoc.2015.11.002"},{"key":"43013","doi-asserted-by":"crossref","unstructured":"Girelli D, Nemeth E, Swinkels DW. Hepcidin in the diagnosis of iron disorders. Blood. 2016; 127(23):2809-2813.","DOI":"10.1182\/blood-2015-12-639112"},{"key":"43014","doi-asserted-by":"crossref","unstructured":"Camaschella C. Iron deficiency. Blood. 2019; 133(1):30-39.","DOI":"10.1182\/blood-2018-05-815944"},{"key":"43015","doi-asserted-by":"crossref","unstructured":"Weiss G, Ganz T, Goodnough LT. Anemia of inflammation. Blood. 2019; 133(1):40-50.","DOI":"10.1182\/blood-2018-06-856500"},{"key":"43016","doi-asserted-by":"crossref","unstructured":"Steinbicker AU, Muckenthaler MU. Out of balance \u2013 systemic iron homeostasis in iron-related disorders. Nutrients. 2013; 5(8):3034-3061.","DOI":"10.3390\/nu5083034"},{"key":"43017","doi-asserted-by":"crossref","unstructured":"Cappellini MD, Comin-Colet J, de Francisco A. Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management. Am J Hematol. 2017; 92(10):1068-1078.","DOI":"10.1002\/ajh.24820"},{"key":"43018","doi-asserted-by":"crossref","unstructured":"Weiss G, Gasche C. Pathogenesis and treatment of anemia in inflammatory bowel disease. Haematologica. 2010; 95(2):175-178.","DOI":"10.3324\/haematol.2009.017046"},{"key":"43019","doi-asserted-by":"crossref","unstructured":"Muckenthaler MU, Rivella S, Hentze MW. A red carpet for iron metabolism. Cell. 2017; 168(3):344-361.","DOI":"10.1016\/j.cell.2016.12.034"},{"key":"43020","doi-asserted-by":"crossref","unstructured":"Valente de Souza L, Hoffmann A, Weiss G. Impact of bacterial infections on erythropoiesis. Expert Rev Anti Infect Ther. 2020; 19(5):619-633.","DOI":"10.1080\/14787210.2021.1841636"},{"key":"43021","doi-asserted-by":"crossref","unstructured":"Katsarou A, Pantopoulos K. Basics and principles of cellular and systemic iron homeostasis. Mol Aspects Med. 2020; 75:100866.","DOI":"10.1016\/j.mam.2020.100866"},{"key":"43022","doi-asserted-by":"crossref","unstructured":"Knutson MD, Vafa MR, Haile DJ. Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood. 2003; 102(12):4191-4197.","DOI":"10.1182\/blood-2003-04-1250"},{"key":"43023","doi-asserted-by":"crossref","unstructured":"Theurl I, Hilgendorf I, Nairz M. On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver. Nat Med. 2016; 22(8):945-951.","DOI":"10.1038\/nm.4146"},{"key":"43024","doi-asserted-by":"crossref","unstructured":"Savin MA, Cook JD. Mucosal iron transport by rat intestine. Blood. 1980; 56(6):1029-1035.","DOI":"10.1182\/blood.V56.6.1029.bloodjournal5661029"},{"key":"43025","doi-asserted-by":"crossref","unstructured":"Nemeth E, Tuttle MS, Powelson J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004; 306(5704):2090-2093.","DOI":"10.1126\/science.1104742"},{"key":"43026","doi-asserted-by":"crossref","unstructured":"Theurl I, Aigner E, Theurl M. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood. 2009; 113(21):5277-5286.","DOI":"10.1182\/blood-2008-12-195651"},{"key":"43027","unstructured":"Means RT. Recent developments in the anemia of chronic disease. Curr Hematol Rep. 2003; 2(2):116-121."},{"key":"43028","doi-asserted-by":"crossref","unstructured":"Camaschella C, Nai A, Silvestri L. Iron metabolism and iron disorders revisited in the hepcidin era. Haematologica. 2020; 105(2):260-272.","DOI":"10.3324\/haematol.2019.232124"},{"key":"43029","doi-asserted-by":"crossref","unstructured":"Pasricha SR, Tye-Din J, Muckenthaler MU. Iron deficiency. Lancet. 2021; 397(10270):233-248.","DOI":"10.1016\/S0140-6736(20)32594-0"},{"key":"43030","doi-asserted-by":"crossref","unstructured":"Theurl I, Mattle V, Seifert M. Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease. Blood. 2006; 107(10):4142-4148.","DOI":"10.1182\/blood-2005-08-3364"},{"key":"43031","doi-asserted-by":"crossref","unstructured":"Thomas DW, Hinchliffe RF, Briggs C. Guideline for the laboratory diagnosis of functional iron deficiency. Br J Haematol. 2013; 161(5):639-648.","DOI":"10.1111\/bjh.12311"},{"key":"43032","doi-asserted-by":"crossref","unstructured":"Brugnara C, Mohandas N. Red cell indices in classification and treatment of anemias: from M.M. Wintrobes's original 1934 classification to the third millennium. Curr Opin Hematol. 2013; 20(3):222-230.","DOI":"10.1097\/MOH.0b013e32835f5933"},{"key":"43033","doi-asserted-by":"crossref","unstructured":"van Santen S, de Mast Q, Oosting JD. Hematologic parameters predicting a response to oral iron therapy in chronic inflammation. Haematologica. 2014; 99(9):e171-173.","DOI":"10.3324\/haematol.2014.106799"},{"key":"43034","doi-asserted-by":"crossref","unstructured":"Weiss G. Anemia of chronic disorders: new diagnostic tools and new treatment strategies. Semin Hematol. 2015; 52(4):313-320.","DOI":"10.1053\/j.seminhematol.2015.07.004"},{"key":"43035","doi-asserted-by":"crossref","unstructured":"Lanser L, Fuchs D, Kurz K. Physiology and inflammation driven pathophysiology of iron homeostasis-mechanistic insights into anemia of inflammation and its treatment. Nutrients. 2021; 13(11):3732.","DOI":"10.3390\/nu13113732"},{"key":"43036","doi-asserted-by":"crossref","unstructured":"Petzer V, Theurl I, Weiss G. Established and emerging concepts to treat imbalances of iron homeostasis in inflammatory diseases. Pharmaceuticals (Basel). 2018; 11(4):135.","DOI":"10.3390\/ph11040135"},{"key":"43037","doi-asserted-by":"crossref","unstructured":"Torti SV, Torti FM. Iron: The cancer connection. Mol Aspects Med. 2020; 75:100860.","DOI":"10.1016\/j.mam.2020.100860"},{"key":"43038","doi-asserted-by":"crossref","unstructured":"Cappellini MD, Musallam KM, Taher AT. Iron deficiency anaemia revisited. J Intern Med. 2020; 287(2):153-170.","DOI":"10.1111\/joim.13004"},{"key":"43039","doi-asserted-by":"crossref","unstructured":"Stoffel NU, Lazrak M, Bellitir S. The opposing effects of acute inflammation and iron deficiency anemia on serum hepcidin and iron absorption in young women. Haematologica. 2019; 104(6):1143-1149.","DOI":"10.3324\/haematol.2018.208645"},{"key":"43040","doi-asserted-by":"crossref","unstructured":"Auerbach M, Gafter-Gvili A, Macdougall IC. Intravenous iron: a framework for changing the management of iron deficiency. Lancet Haematol. 2020; 7(4):e342-e350.","DOI":"10.1016\/S2352-3026(19)30264-9"},{"key":"43041","doi-asserted-by":"crossref","unstructured":"Koskenkorva-Frank TS, Weiss G, Koppenol WH. The complex interplay of iron metabolism, reactive oxygen species, and reactive nitrogen species: insights into the potential of various iron therapies to induce oxidative and nitrosative stress. Free Radic Biol Med. 2013; 65:1174-1194.","DOI":"10.1016\/j.freeradbiomed.2013.09.001"},{"key":"43042","doi-asserted-by":"crossref","unstructured":"Theurl I, Schroll A, Nairz M. Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo. Haematologica. 2011; 96(12):1761-1769.","DOI":"10.3324\/haematol.2011.048926"},{"key":"43043","doi-asserted-by":"crossref","unstructured":"Petzer V, Tymoszuk P, Asshoff M. A fully human anti-BMP6 antibody reduces the need for erythropoietin in rodent models of the anemia of chronic disease. Blood. 2020; 136(9):1080-1090.","DOI":"10.1182\/blood.2019004653"},{"key":"43044","doi-asserted-by":"crossref","unstructured":"Andriopoulos B, Corradini E, Xia Y. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet. 2009; 41(4):482-487.","DOI":"10.1038\/ng.335"},{"key":"43045","doi-asserted-by":"crossref","unstructured":"Mancias JD, Wang X, Gygi SP. Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature. 2014; 509(7498):105-109.","DOI":"10.1038\/nature13148"},{"key":"43046","doi-asserted-by":"crossref","unstructured":"Gunshin H, Mackenzie B, Berger UV. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature. 1997; 388(6641):482-488.","DOI":"10.1038\/41343"},{"key":"43047","doi-asserted-by":"crossref","unstructured":"Barrand MA, Callingham BA, Dobbin P. Dissociation of a ferric maltol complex and its subsequent metabolism during absorption across the small intestine of the rat. Br J Pharmacol. 1991; 102(3):723-729.","DOI":"10.1111\/j.1476-5381.1991.tb12240.x"},{"key":"43048","doi-asserted-by":"crossref","unstructured":"Ludwiczek S, Aigner E, Theurl I. Cytokine-mediated regulation of iron transport in human monocytic cells. Blood. 2003; 101(10):4148-4154.","DOI":"10.1182\/blood-2002-08-2459"},{"key":"43049","doi-asserted-by":"crossref","unstructured":"Lasocki S, Millot S, Andrieu V. Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia. Crit Care Med. 2008; 36(8):2388-2394.","DOI":"10.1097\/CCM.0b013e31818103b9"},{"key":"43050","doi-asserted-by":"crossref","unstructured":"Nairz M, Weiss G. Iron in infection and immunity. Mol Aspects Med. 2020; 75:100864.","DOI":"10.1016\/j.mam.2020.100864"},{"key":"43051","doi-asserted-by":"crossref","unstructured":"Ganz T, Nemeth E. Iron homeostasis in host defence and inflammation. Nat Rev Immunol. 2015; 15(8):500-510.","DOI":"10.1038\/nri3863"},{"key":"43052","doi-asserted-by":"crossref","unstructured":"Fillebeen C, Wilkinson N, Charlebois E. Hepcidin-mediated hypoferremic response to acute inflammation requires a threshold of Bmp6\/Hjv\/Smad signaling. Blood. 2018; 132(17):1829-1841.","DOI":"10.1182\/blood-2018-03-841197"},{"key":"43053","doi-asserted-by":"crossref","unstructured":"Armitage AE, Eddowes LA, Gileadi U. Hepcidin regulation by innate immune and infectious stimuli. Blood. 2011; 118(15):4129-4139.","DOI":"10.1182\/blood-2011-04-351957"},{"key":"43054","doi-asserted-by":"crossref","unstructured":"Cercamondi CI, Stoffel NU, Moretti D. Iron homeostasis during anemia of inflammation: a prospective study of patients with tuberculosis. Blood. 2021; 138(15):1293-1303.","DOI":"10.1182\/blood.2020010562"},{"key":"43055","doi-asserted-by":"crossref","unstructured":"Prentice AM, Doherty CP, Abrams SA. Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood. 2012; 119(8):1922-1928.","DOI":"10.1182\/blood-2011-11-391219"},{"key":"43056","doi-asserted-by":"crossref","unstructured":"Roth MP, Meynard D, Coppin H. Regulators of hepcidin expression. Vitamin Horm. 2019; 110:101-129.","DOI":"10.1016\/bs.vh.2019.01.005"},{"key":"43057","doi-asserted-by":"crossref","unstructured":"Oexle H, Kaser A, M\u00f6st J. Pathways for the regulation of interferon-gamma-inducible genes by iron in human monocytic cells. J Leukoc Biol. 2003; 74(2):287-294.","DOI":"10.1189\/jlb.0802420"},{"key":"43058","doi-asserted-by":"crossref","unstructured":"Sonnweber T, Theurl I, Seifert M. Impact of iron treatment on immune effector function and cellular iron status of circulating monocytes in dialysis patients. Nephrol Dail Transplant. 2011; 26(3):977-987.","DOI":"10.1093\/ndt\/gfq483"},{"key":"43059","doi-asserted-by":"crossref","unstructured":"Poljak-Blazi M, Jaganjac M, Mustapic M. Acute immunomodulatory effects of iron polyisomaltosate in rats. Immunobiology. 2009; 214(2):121-128.","DOI":"10.1016\/j.imbio.2008.07.005"},{"key":"43060","doi-asserted-by":"crossref","unstructured":"Arezes J, Foy N, McHugh K. Erythroferrone inhibits the induction of hepcidin by BMP6. Blood. 2018; 132(14):1473-1477.","DOI":"10.1182\/blood-2018-06-857995"},{"key":"43061","doi-asserted-by":"crossref","unstructured":"Zoller H, Weiss G, Theurl I. Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload. Gastroenterology. 2001; 120(6):1412-1419.","DOI":"10.1053\/gast.2001.24033"},{"key":"43062","doi-asserted-by":"crossref","unstructured":"Ludwiczek S, Theurl I, Artner-Dworzak E. Duodenal HFE expression and hepcidin levels determine body iron homeostasis: modulation by genetic diversity and dietary iron availability. J Mol Med. 2004; 82(6):373-382.","DOI":"10.1007\/s00109-004-0542-3"},{"key":"43063","doi-asserted-by":"crossref","unstructured":"Renassia C, Peyssonnaux C. New insights into the links between hypoxia and iron homeostasis. Curr Opin Hematol. 2019; 26(3):125-130.","DOI":"10.1097\/MOH.0000000000000494"},{"key":"43064","doi-asserted-by":"crossref","unstructured":"Goetze O, Schmitt J, Spliethoff K. Adaptation of iron transport and metabolism to acute high-altitude hypoxia in mountaineers. Hepatology. 2013; 58(6):2153-2162.","DOI":"10.1002\/hep.26581"},{"key":"43065","doi-asserted-by":"crossref","unstructured":"Papanikolaou G, Pantopoulos K. Systemic iron homeostasis and erythropoiesis. IUBMB Life. 2017; 69(6):399-413.","DOI":"10.1002\/iub.1629"},{"key":"43066","doi-asserted-by":"crossref","unstructured":"Litton E, Baker S, Erber WN. Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial : a randomized trial of IV iron in critical illness. Intensive Care Med. 2016; 42(11):1715-1722.","DOI":"10.1007\/s00134-016-4465-6"},{"key":"43067","doi-asserted-by":"crossref","unstructured":"Stoffel NU, Zeder C, Brittenham GM. Iron absorption from supplements is greater with alternate day than with consecutive day dosing in iron-deficient anemic women. Haematologica. 2020; 105(5):1232-1239.","DOI":"10.3324\/haematol.2019.220830"},{"key":"43068","doi-asserted-by":"crossref","unstructured":"Khalil S, Delehanty L, Grado S. Iron modulation of erythropoiesis is associated with Scribble-mediated control of the erythropoietin receptor. J Exp Med. 2018; 215(2):661-679.","DOI":"10.1084\/jem.20170396"},{"key":"43069","doi-asserted-by":"crossref","unstructured":"Weiss G, Houston T, Kastner S. Regulation of cellular iron metabolism by erythropoietin: activation of iron-regulatory protein and upregulation of transferrin receptor expression in erythroid cells. Blood. 1997; 89(2):680-687.","DOI":"10.1182\/blood.V89.2.680"},{"key":"43070","doi-asserted-by":"crossref","unstructured":"Nairz M, Schroll A, Moschen AR. Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-\u03baB-inducible immune pathways. Immunity. 2011; 34(1):61-74.","DOI":"10.1016\/j.immuni.2011.01.002"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.281149\/74630","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2022.281149\/75160","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/10704\/74630","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:01:59Z","timestamp":1794045719000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2022.281149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,7]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2022.281149","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,7]]}}}